According to the latest equity disclosure information of the Stock Exchange, from December 24 to December 30, 2021, Chuangsheng Group-B (06628.HK) was acquired by Qian Xueming, executive director and chief executive officer of Chuangsheng Group,000 shares, at an average price of HK$9.313-9.429 per share, with a total increase of 313,000 shares, involving about HK$2.939 million.
After the increase in shareholding, Qian Xueming's latest shareholding number was 57.6079 million shares, and the shareholding ratio increased from 12.87% to 12.94%.
This article originated from Grand Gateway
![There is a lung cancer with a low degree of malignancy, most of which do not require any treatment after surgery Recently a netizen consultation platform consultation, which is a postoperative lung cancer patient, one month after surgery, the pathological stage is I[fig]](data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACwAAAAAAQABAAACAkQBADs=)